Advertisement
Research Article

Efficacy of the New Neuraminidase Inhibitor CS-8958 against H5N1 Influenza Viruses

  • Maki Kiso,

    Affiliation: Division of Virology, Department of Microbiology and Immunology, Institute of Medical Science, University of Tokyo, Shirokanedai, Minato-ku, Tokyo, Japan

    X
  • Shuku Kubo,

    Affiliation: Biological Research Laboratories, Daiichi Sankyo Co. Ltd., Hiromachi, Shinagawa-ku, Tokyo, Japan

    X
  • Makoto Ozawa,

    Affiliations: International Research Center for Infectious Diseases, Institute of Medical Science, University of Tokyo, Shirokanedai, Minato-ku, Tokyo, Japan, Department of Pathobiological Sciences, University of Wisconsin, Madison, Wisconsin, United States of America

    X
  • Quynh Mai Le,

    Affiliation: National Institute of Hygiene and Epidemiology, Hanoi, Vietnam

    X
  • Chairul A. Nidom,

    Affiliation: Faculty of Veterinary Medicine, Tropical Disease Centre, Airlangga University, Surabaya, Indonesia

    X
  • Makoto Yamashita,

    Affiliation: Biological Research Laboratories, Daiichi Sankyo Co. Ltd., Hiromachi, Shinagawa-ku, Tokyo, Japan

    X
  • Yoshihiro Kawaoka mail

    kawaoka@ims.u-tokyo.ac.jp

    Affiliations: Division of Virology, Department of Microbiology and Immunology, Institute of Medical Science, University of Tokyo, Shirokanedai, Minato-ku, Tokyo, Japan, International Research Center for Infectious Diseases, Institute of Medical Science, University of Tokyo, Shirokanedai, Minato-ku, Tokyo, Japan, Department of Pathobiological Sciences, University of Wisconsin, Madison, Wisconsin, United States of America, ERATO Infection-Induced Host Responses Project, Japan Science and Technology Agency, Saitama, Japan, International Center for Medical Research and Treatment, Graduate School of Medicine, Kobe University, Chuo-ku, Hyogo, Japan

    X
  • Published: February 26, 2010
  • DOI: 10.1371/journal.ppat.1000786

Reader Comments (0)

Post a new comment on this article